HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Role of mammalian chitinases in inflammatory conditions.

Abstract
It has been hypothesized that dysregulated host/microbial interactions play a pivotal role in the pathogenesis of inflammatory bowel disease. However, the exact mechanisms underlying the induction and perpetuation of the intestinal disorder are unclear. Recently, we unexpectedly discovered significantly upregulated gene expression of chitinase 3-like-1 in inflamed colon of the dextran sulfate sodium-induced colitis model by employing the DNA-microarray analysis. Chitinase 3-like-1 has a chitin binding ability, but lacks the enzymatic activity of lysing microbial cell wall. Chitinase 3-like-1 protein is mainly expressed in colonic epithelial cells and macrophages in the inflamed colon of dextran sulfate sodium-induced colitis. Chitinase 3-like-1, which can be upregulated after pro-inflammatory cytokine stimulation, possesses an ability to enhance the adhesion and internalization of intracellular bacteria into colonic epithelial cells. Most importantly, in vivo neutralization of chitinase 3-like-1 significantly suppressed the development of dextran sulfate sodium-induced colitis by dramatically decreasing the bacterial adhesion and invasion into colonic epithelial cells. Furthermore, anti-chitinase 3-like-1 antibody-treated mice exhibited a significantly lower load of Salmonella typhimurium in peripheral organs as compared to control rabbit IgG-treated mice. Recently, it has been reported that acidic mammalian chitinase is expressed in the setting of T helper-2-associated inflammation and subsequently induces airway hyperresponsiveness in allergic asthma patients. In addition, pan-chitinase inhibitor significantly ameliorates T helper-2-mediated inflammation and airway hypersensitivity. These studies provide to be a novel insight into the physiological role of mammalian chitinases in host/microbial interactions, and inhibition of chitinase activity would be considered a novel therapeutic strategy of allergic and inflammatory disorders.
AuthorsMayumi Kawada, Yuriko Hachiya, Atsuko Arihiro, Emiko Mizoguchi
JournalThe Keio journal of medicine (Keio J Med) Vol. 56 Issue 1 Pg. 21-7 (Mar 2007) ISSN: 0022-9717 [Print] Japan
PMID17392594 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Adipokines
  • Bacterial Proteins
  • CHI3L1 protein, human
  • Carrier Proteins
  • Enzyme Inhibitors
  • Glycoproteins
  • Lectins
  • chitin-binding protein 21, Serratia marcescens
  • CHIA protein, human
  • Chitinase
Topics
  • Adipokines
  • Animals
  • Bacterial Proteins (physiology)
  • Carrier Proteins (physiology)
  • Chitinase (antagonists & inhibitors, physiology)
  • Enzyme Inhibitors (therapeutic use)
  • Glycoproteins (physiology)
  • Humans
  • Inflammation (etiology)
  • Inflammatory Bowel Diseases (etiology)
  • Lectins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: